The second strategy is the direct immunoprecipitation of MHC-peptide complexes from tumor cells and identification of bound peptide sequences by liquid chromatography-mass spectrometry (LC-MS/MS) with subsequent matching to exome or transcriptomic reads. Here, HLA-C is linked to neoplasm.